https://stock.noler.com/us/stock/q-therapeutics-inc https://stock.noler.com/us/stock/q-therapeutics-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/q-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/q-therapeutics-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/accounts-receivable-billed-for-long-term-contracts-or-programs https://stock.noler.com/us/stock/q-therapeutics-inc/accretion-expense-including-asset-retirement-obligations https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-bonuses-current https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-salaries-current https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-salaries-current-and-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-vacation-current https://stock.noler.com/us/stock/q-therapeutics-inc/accrued-vacation-current-and-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/q-therapeutics-inc/acquisition-step-acquisition-equity-interest-in-acquiree-percentage https://stock.noler.com/us/stock/q-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/q-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/q-therapeutics-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/q-therapeutics-inc/allowance-for-doubtful-other-receivables-current https://stock.noler.com/us/stock/q-therapeutics-inc/allowance-for-loan-and-lease-losses-recoveries-of-bad-debts https://stock.noler.com/us/stock/q-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/q-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/q-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/q-therapeutics-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/q-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/q-therapeutics-inc/bridge-loan https://stock.noler.com/us/stock/q-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/q-therapeutics-inc/cash https://stock.noler.com/us/stock/q-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/q-therapeutics-inc/cash-change https://stock.noler.com/us/stock/q-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/q-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/q-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/q-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/q-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/q-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/q-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/q-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/q-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/q-therapeutics-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/q-therapeutics-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/q-therapeutics-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/q-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/q-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/q-therapeutics-inc/current-assets https://stock.noler.com/us/stock/q-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/q-therapeutics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/q-therapeutics-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/q-therapeutics-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/q-therapeutics-inc/debt-convertible-interest-expense https://stock.noler.com/us/stock/q-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/q-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/q-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/q-therapeutics-inc/debt-issuance-costs https://stock.noler.com/us/stock/q-therapeutics-inc/debt-redemption-price-percentage https://stock.noler.com/us/stock/q-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/q-therapeutics-inc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/q-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/q-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/q-therapeutics-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/q-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/q-therapeutics-inc/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/q-therapeutics-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/q-therapeutics-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/q-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/q-therapeutics-inc/depreciation-nonproduction https://stock.noler.com/us/stock/q-therapeutics-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/q-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/q-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/q-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/q-therapeutics-inc/due-from-related-parties-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/q-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/q-therapeutics-inc/eps https://stock.noler.com/us/stock/q-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/q-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/q-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/q-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/q-therapeutics-inc/grants-receivable https://stock.noler.com/us/stock/q-therapeutics-inc/grants-receivable-current https://stock.noler.com/us/stock/q-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/q-therapeutics-inc/impaired-assets-to-be-disposed-of-by-method-other-than-sale-amount-of-impairment-loss https://stock.noler.com/us/stock/q-therapeutics-inc/income-tax https://stock.noler.com/us/stock/q-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/q-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/q-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/q-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/q-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/q-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/q-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/q-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/q-therapeutics-inc/interest-income-other https://stock.noler.com/us/stock/q-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/q-therapeutics-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/q-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/q-therapeutics-inc/investment-warrants-exercise-price https://stock.noler.com/us/stock/q-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/q-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/q-therapeutics-inc/leveraged-buyout-ownership-interest-of-new-investors https://stock.noler.com/us/stock/q-therapeutics-inc/liabilities-fair-value-disclosure-recurring https://stock.noler.com/us/stock/q-therapeutics-inc/license-and-services-revenue https://stock.noler.com/us/stock/q-therapeutics-inc/license-costs https://stock.noler.com/us/stock/q-therapeutics-inc/long-term-notes-payable https://stock.noler.com/us/stock/q-therapeutics-inc/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/q-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/q-therapeutics-inc/net-income https://stock.noler.com/us/stock/q-therapeutics-inc/non-hedging-derivatives-liability-at-fair-value https://stock.noler.com/us/stock/q-therapeutics-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/q-therapeutics-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/q-therapeutics-inc/notes-assumed https://stock.noler.com/us/stock/q-therapeutics-inc/notes-issued https://stock.noler.com/us/stock/q-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/q-therapeutics-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/q-therapeutics-inc/notes-payable-related-parties-current https://stock.noler.com/us/stock/q-therapeutics-inc/notes-reduction https://stock.noler.com/us/stock/q-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/q-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/q-therapeutics-inc/operating-income https://stock.noler.com/us/stock/q-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/q-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/q-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/q-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/q-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/q-therapeutics-inc/other-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/q-therapeutics-inc/other-assets https://stock.noler.com/us/stock/q-therapeutics-inc/other-employee-related-liabilities-current https://stock.noler.com/us/stock/q-therapeutics-inc/other-income https://stock.noler.com/us/stock/q-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/q-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/q-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/q-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/q-therapeutics-inc/paid-in-capital-other https://stock.noler.com/us/stock/q-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/q-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/q-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/q-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/q-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/q-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/q-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/q-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/q-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/q-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/q-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/q-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-collection-of-advance-to-affiliate https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-grantors https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-short-term-debt-maturing-in-more-than-three-months https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-unsecured-notes-payable https://stock.noler.com/us/stock/q-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/q-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/q-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/q-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/q-therapeutics-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/q-therapeutics-inc/public-float https://stock.noler.com/us/stock/q-therapeutics-inc/receivable-from-officers-and-directors-for-issuance-of-capital-stock https://stock.noler.com/us/stock/q-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/q-therapeutics-inc/related-party-transaction-rate https://stock.noler.com/us/stock/q-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/q-therapeutics-inc/repayments-of-other-debt https://stock.noler.com/us/stock/q-therapeutics-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/q-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/q-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/q-therapeutics-inc/revenue https://stock.noler.com/us/stock/q-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/q-therapeutics-inc/revenue-other-manufactured-products https://stock.noler.com/us/stock/q-therapeutics-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/q-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/q-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/q-therapeutics-inc/secured-debt-current https://stock.noler.com/us/stock/q-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/q-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/q-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/q-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/q-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/q-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/q-therapeutics-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/q-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/q-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/q-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/q-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/q-therapeutics-inc/shares-issued-shares-other https://stock.noler.com/us/stock/q-therapeutics-inc/shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/q-therapeutics-inc/shares-outstanding-2 https://stock.noler.com/us/stock/q-therapeutics-inc/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-non-option-equity-instruments-forfeitures https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-rsu-aggregate-intrinsic-value-outstanding https://stock.noler.com/us/stock/q-therapeutics-inc/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/q-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/q-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/q-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised-net-of-tax-benefit-expense https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/q-therapeutics-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/q-therapeutics-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/q-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/q-therapeutics-inc/stockholders-equity-other https://stock.noler.com/us/stock/q-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/q-therapeutics-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/q-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/q-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/q-therapeutics-inc/total-assets https://stock.noler.com/us/stock/q-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/q-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/q-therapeutics-inc/unsecured-debt-current https://stock.noler.com/us/stock/q-therapeutics-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/q-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted